Cyclo/gaba 10/300 Pack
NDC Package 69176-100-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Cyclo/gaba 10/300 Pack is gabapentin is contraindicated in patients who havedemonstrated hypersensitivity to the drug or its ingredients. Marketed by Tmig Inc., this product is identified by NDC 69176-100 and is authorized under FDA application ANDA090858.

Identification & Billing

NDC Package Code
69176-100-02
Package Description
1 KIT in 1 KIT
Product Code
69176-100
11-Digit Billing Format
69176010002
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Cyclo/gaba 10/300 Pack
Dosage Form
-
Usage Information
Gabapentin is contraindicated in patients who havedemonstrated hypersensitivity to the drug or its ingredients.

Regulatory & Marketing

Labeler Name
Tmig Inc.
FDA Application #
ANDA090858
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-29-2011
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69176-100-02 identifies a specific commercial package of 1 kit in 1 kit of Cyclo/gaba 10/300 Pack, labeled by Tmig Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Tmig Inc. on January 29, 2011. The current certification is valid through December 31, 2017.

How is this Tmig Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69176010002. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69176-100-02
11-Digit CMS (5-4-2)
69176-0100-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.